Xarelto Lawsuit Smackdown

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use - and failure to perform so could be grounds for compensation. Our lawyers are functioning tough to obtain those hurt by the drug the compensation they're entitled to.

While bleeding is a common complication linked with anticoagulants, it has been alleged that Xarelto is far more unsafe than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, individuals may be at threat for irreversible bleeding troubles, including life-threatening internal and gastrointestinal hemorrhaging.

If you or possibly a loved a single suffered a serious bleeding occasion following taking Xarelto, you might have legal recourse. For far more details, contact us nowadays to possess your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in cases of death, funeral costs. Additionally, they may be searching for punitive damages, which are normally awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit relevant resource site this page for more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.